
Assembly Biosciences ASMB
$ 22.74
0.89%
Assembly Biosciences P/B Ratio | ASMB
Annual P/B Ratio Assembly Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.49 | 4.95 | 1.48 | 0.062 | 0.397 | 0.824 | 1.7 | 2.38 | 7.85 | 4.09 | 0.677 | 1 | 3.1 | 1.81 | 2.44 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.85 | 0.062 | 2.28 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EyePoint Pharmaceuticals
EYPT
|
0.00377 | $ 3.15 | 0.62 % | $ 231 K | ||
|
Fate Therapeutics
FATE
|
0.585 | $ 2.43 | 4.74 % | $ 289 M | ||
|
Fortress Biotech
FBIO
|
1.25 | $ 2.09 | 2.96 % | $ 58.3 M | ||
|
Fennec Pharmaceuticals
FENC
|
4.76 | $ 10.62 | 4.12 % | $ 303 M | ||
|
Fulcrum Therapeutics
FULC
|
1.54 | $ 3.71 | 0.54 % | $ 235 M | ||
|
Merus N.V.
MRUS
|
4.6 | - | - | $ 5.78 B | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 3.73 | 3.72 % | $ 238 M | ||
|
Geron Corporation
GERN
|
4.69 | $ 1.21 | 0.83 % | $ 807 M | ||
|
Gilead Sciences
GILD
|
3.11 | $ 144.63 | 0.85 % | $ 180 B | ||
|
Greenwich LifeSciences
GLSI
|
1.09 K | $ 16.91 | 0.77 % | $ 229 M | ||
|
Genmab A/S
GMAB
|
0.052 | $ 38.48 | 10.73 % | $ 2.49 B | ||
|
Genprex
GNPX
|
0.207 | $ 2.72 | 3.42 % | $ 2.54 M | ||
|
Gossamer Bio
GOSS
|
-0.875 | $ 10.65 | 0.37 % | $ 2.43 B | ||
|
GeoVax Labs
GOVX
|
0.321 | $ 0.32 | 1.31 % | $ 307 K | ||
|
Grifols, S.A.
GRFS
|
0.525 | $ 7.41 | 1.37 % | $ 5.04 B | ||
|
GlaxoSmithKline plc
GSK
|
13.6 | $ 46.55 | 0.93 % | $ 189 B | ||
|
GT Biopharma
GTBP
|
0.382 | $ 6.16 | 0.98 % | $ 34 M | ||
|
Halozyme Therapeutics
HALO
|
198 | $ 108.31 | 2.73 % | $ 13 B | ||
|
Hutchison China MediTech Limited
HCM
|
9.59 | $ 14.31 | 0.77 % | $ 12.3 B | ||
|
Harmony Biosciences Holdings
HRMY
|
1.85 | $ 39.92 | 0.71 % | $ 2.3 B | ||
|
Heron Therapeutics
HRTX
|
13.8 | $ 0.37 | 6.44 % | $ 61.7 M | ||
|
iBio
IBIO
|
1.65 | $ 1.12 | 0.89 % | $ 117 M | ||
|
ImmuCell Corporation
ICCC
|
2.15 | $ 9.75 | 1.56 % | $ 88 M | ||
|
IDEAYA Biosciences
IDYA
|
2.66 | $ 38.06 | 1.87 % | $ 3.37 B | ||
|
InflaRx N.V.
IFRX
|
1.52 | $ 1.68 | 0.58 % | $ 113 M | ||
|
Immutep Limited
IMMP
|
20.7 | $ 4.27 | 0.46 % | $ 6.22 B | ||
|
Immunome
IMNM
|
2.98 | $ 21.17 | 1.29 % | $ 1.85 B | ||
|
Immuron Limited
IMRN
|
28.6 | $ 1.07 | 0.46 % | $ 247 M | ||
|
Immatics N.V.
IMTX
|
1.31 | $ 7.73 | 1.84 % | $ 946 M | ||
|
Immunic
IMUX
|
-21.7 | $ 8.07 | 1.38 % | $ 1.26 B | ||
|
Immunovant
IMVT
|
7.61 | $ 33.25 | 0.18 % | $ 6.07 B | ||
|
Innate Pharma S.A.
IPHA
|
2.01 | $ 1.58 | 1.28 % | $ 142 M | ||
|
Incyte Corporation
INCY
|
3.77 | $ 114.13 | 0.06 % | $ 22.3 B | ||
|
InMed Pharmaceuticals
INM
|
5.07 | $ 1.33 | 0.01 % | $ 5.54 M | ||
|
INmune Bio
INMB
|
1.2 | $ 1.94 | 0.52 % | $ 48 M | ||
|
Inovio Pharmaceuticals
INO
|
4.09 | $ 1.15 | 2.05 % | $ 53.9 M | ||
|
Insmed Incorporated
INSM
|
42.8 | $ 103.83 | 2.33 % | $ 20.7 B | ||
|
Innoviva
INVA
|
0.992 | $ 20.64 | 0.68 % | $ 1.39 B | ||
|
Iovance Biotherapeutics
IOVA
|
0.00193 | $ 14.15 | 0.63 % | $ 5.06 M | ||
|
Ironwood Pharmaceuticals
IRWD
|
0.253 | $ 3.65 | 0.27 % | $ 591 M | ||
|
Inventiva S.A.
IVA
|
-1.72 | $ 3.48 | 2.89 % | $ 208 M | ||
|
Jaguar Health
JAGX
|
-0.0512 | $ 4.73 | 29.23 % | $ 11 M | ||
|
Jazz Pharmaceuticals plc
JAZZ
|
0.904 | $ 236.04 | 0.16 % | $ 14.4 B | ||
|
Johnson & Johnson
JNJ
|
5.3 | $ 252.93 | 0.03 % | $ 609 B | ||
|
Kala Pharmaceuticals
KALA
|
0.233 | $ 0.36 | 0.86 % | $ 2.93 M | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
5.77 | $ 76.31 | 0.69 % | $ 5.66 B | ||
|
Kodiak Sciences
KOD
|
12.9 | $ 93.81 | 0.32 % | $ 4.99 B | ||
|
Karyopharm Therapeutics
KPTI
|
-0.000154 | $ 0.67 | 1.51 % | $ 7.33 K | ||
|
Keros Therapeutics
KROS
|
1.69 | $ 11.52 | 1.41 % | $ 429 M | ||
|
Krystal Biotech
KRYS
|
6.94 | $ 334.85 | 3.9 % | $ 9.69 B |